No Detail Found!

Is central anticholinergic syndrome linked to opioid use for cervical cancer pain?

Author(s)
Alex Choi Palliative Care Program, PO box 332332, New Haven, CT, USA
Trinh Bui Palliative Care Program, PO box 332332, New Haven, CT, USA
Eva Y. Pan Palliative Care Program, PO box 332332, New Haven, CT, USA
Mehmet Ozcan Palliative Care Program, PO box 332332, New Haven, CT, USA
Abstract
Central anticholinergic syndrome (CAS) presents with central and/or peripheral neurological symptoms after exposure to anticholinergic medication. Pain management is a challenge for patients who have CAS and concurrent cancer-related pain. We present a patient who became lethargic and unresponsive after receiving butorphanol, with persistent symptoms despite administration of an opioid antagonist. This case report is the first to suggest a causal relationship between opioids and CAS without the presence of confounding anticholinergic medications. CAS should be considered for patients who develop neurological symptoms after opioid exposure and have an incomplete response to an opioid antagonist.
Publication Details
Page(s) 831-835
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 26, Issue: 6, Year: 2022

Request the full text from PASTIC

Keywords
opioids, case report, Cancer-Related Pain, Central Anticholinergic Syndrome, Anticholinergic Toxicity, Butorphanol
0

Citations

0

Downloads

31

Views